Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000540407 | SCV000654762 | likely benign | Hereditary sensory and autonomic neuropathy type 7; Familial episodic pain syndrome with predominantly lower limb involvement | 2024-01-19 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001653919 | SCV001866683 | benign | not provided | 2018-11-28 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 26423924) |
Ce |
RCV001653919 | SCV002544792 | benign | not provided | 2023-04-01 | criteria provided, single submitter | clinical testing | SCN11A: BS1, BS2 |
Ambry Genetics | RCV002341454 | SCV002640566 | likely benign | Inborn genetic diseases | 2019-09-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Clinical Genetics, |
RCV001653919 | SCV001924012 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001653919 | SCV001958476 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001653919 | SCV001968235 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003962591 | SCV004789717 | likely benign | SCN11A-related disorder | 2021-04-08 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |